NISA INVESTMENT ADVISORS, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 206 filers reported holding FATE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,053
-58.6%
1,440
-7.0%
0.00%
Q2 2023$7,373
+23683.9%
1,549
-71.9%
0.00%
Q1 2023$31
+933.3%
5,505
+1735.0%
0.00%
Q4 2022$3
-100.0%
300
-87.8%
0.00%
Q3 2022$51,000
-1.9%
2,462
+17.2%
0.00%
Q2 2022$52,000
-42.9%
2,100
-11.0%
0.00%
-100.0%
Q1 2022$91,000
-13.3%
2,360
-7.1%
0.00%0.0%
Q4 2021$105,000
-39.0%
2,540
-12.4%
0.00%0.0%
Q3 2021$172,000
-36.1%
2,900
-6.5%
0.00%
-50.0%
Q2 2021$269,000
-7.6%
3,100
-12.2%
0.00%0.0%
Q1 2021$291,000
-18.5%
3,530
-10.2%
0.00%0.0%
Q4 2020$357,000
+264.3%
3,930
+60.1%
0.00%
+100.0%
Q3 2020$98,000
+415.8%
2,455
+342.3%
0.00%
Q2 2020$19,000
+58.3%
555
+5.7%
0.00%
Q1 2020$12,0000.0%525
-12.5%
0.00%
Q4 2019$12,000
+33.3%
6000.0%0.00%
Q3 2019$9,0000.0%600
+39.5%
0.00%
Q2 2019$9,000
+12.5%
4300.0%0.00%
Q1 2019$8,000
+33.3%
4300.0%0.00%
Q4 2018$6,000
-14.3%
4300.0%0.00%
Q3 2018$7,0004300.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders